Showing results (241-250 of 295) with videos related to
Sort By:
Pageof 30
Viruses|September 28, 2021
Dual Effect of Organogermanium Compound THGP on RIG-I-Mediated Viral Sensing and Viral Replication during Influenza a Virus InfectionSunanda Baidya, Yoko Nishimoto, Seiichi Sato, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2021
Hepatectomy Followed by mFOLFOX6 Versus Hepatectomy Alone for Liver-Only Metastatic Colorectal Cancer (JCOG0603): A Phase II or III Randomized Controlled TrialYukihide Kanemitsu, Yasuhiro Shimizu, Junki Mizusawa, et al.The Lancet. Oncology|November 15, 2013
Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trialYasuhide Yamada, Daisuke Takahari, Hiroshi Matsumoto, et al.Cancer Science|October 30, 2008
Identification of prognostic biomarkers in gastric cancer using endoscopic biopsy samplesYasuhide Yamada, Tokuzo Arao, Takuji Gotoda, et al.Journal of Cancer Research and Clinical Oncology|August 10, 2014
A phase 3 non-inferiority study of 5-FU/l-leucovorin/irinotecan (FOLFIRI) versus irinotecan/S-1 (IRIS) as second-line chemotherapy for metastatic colorectal cancer: updated results of the FIRIS studyHirofumi Yasui, Kei Muro, Yasuhiro Shimada, et al.Journal of Gastroenterology and Hepatology|September 30, 2017
Age does not influence efficacy of ramucirumab in advanced gastric cancer: Subgroup analyses of REGARD and RAINBOWKei Muro, Jae Yong Cho, Gyorgy Bodoky, et al.Plos One|August 16, 2014
Application of a combination of a knowledge-based algorithm and 2-stage screening to hypothesis-free genomic data on irinotecan-treated patients for identification of a candidate single nucleotide polymorphism related to an adverse effectHiro Takahashi, Kimie Sai, Yoshiro Saito, et al.Cancer Science|May 15, 2023
Genomic landscape and its prognostic significance in stage III colorectal cancer: JCOG1506A1, an ancillary of JCOG0910Dai Shida, Aya Kuchiba, Tatsuhiro Shibata, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 24, 2024
Localized colorectal cancer database integrating 4 randomized controlled trials; (JCOG2310A)Kozo Kataoka, Akira Ouchi, Yusuke Suwa, et al.ESMO Open|August 2, 2017
S-1 and oxaliplatin (SOX) plus bevacizumab versus mFOLFOX6 plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer: updated overall survival analyses of the open-label, non-inferiority, randomised phase III: SOFT studyHideo Baba, Yasuhide Yamada, Daisuke Takahari, et al.Pageof 30